UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Beyond Consumption: India's New Middle Class in the Neo-Liberal Times

1, 2022

Volltextzugriff (PDF)

Pharmacological Treatments for Patients with Treatment-Resistant Depression

Pharmaceuticals (Basel, Switzerland), 2020-06, Vol.13 (6), p.116

2020

Volltextzugriff (PDF)

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Molecular psychiatry, 2020-07, Vol.25 (7), p.1592-1603

2020

Volltextzugriff (PDF)

A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder

The American journal of psychiatry, 2021-02, Vol.178 (2), p.193-202

2021

Volltextzugriff (PDF)

Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks

Journal of affective disorders, 2018-06, Vol.233, p.3-14

2018

Volltextzugriff (PDF)

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation

International journal of molecular sciences, 2018-01, Vol.19 (1), p.233

2018

Volltextzugriff (PDF)

Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial

The American journal of psychiatry, 2021-05, Vol.178 (5), p.437-446

2021

Volltextzugriff (PDF)

Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial

The American journal of psychiatry, 2016-12, Vol.173 (12), p.1196-1204

2016

Volltextzugriff (PDF)

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study

Translational psychiatry, 2023-04, Vol.13 (1), p.139-139, Article 139

2023

Volltextzugriff (PDF)

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients

PloS one, 2016-12, Vol.11 (12), p.e0167901-e0167901

2016

Volltextzugriff (PDF)

A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project

Annals of family medicine, 2019-07, Vol.17 (4), p.326-335

2019

Volltextzugriff (PDF)

Smoking status links habenular volume to glycated hemoglobin: Findings from the Human Connectome Project-Young Adult

Psychoneuroendocrinology, 2021-09, Vol.131, p.105321-105321, Article 105321

2021

Volltextzugriff (PDF)

The clinical, economic, and patient‐centric burden of insomnia symptom severity in adults with major depressive disorder in the United States

Brain and behavior, 2023-08, Vol.13 (8), p.e3143-n/a

2023

Volltextzugriff (PDF)

Is C-reactive protein ready for prime time in the selection of antidepressant medications?

Psychoneuroendocrinology, 2017-10, Vol.84, p.206-206

2017

Volltextzugriff (PDF)

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape

The American journal of psychiatry, 2023-03, Vol.180 (3), p.190-199

2023

Volltextzugriff (PDF)

Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial

Journal of psychiatric research, 2017-11, Vol.94, p.1-6

2017

Volltextzugriff (PDF)

Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2019-04, Vol.73 (14), p.1827-1845

2019

Volltextzugriff (PDF)

A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial

Psychotherapy and psychosomatics, 2018-01, Vol.87 (5), p.285-295

2018

Volltextzugriff (PDF)

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory

Translational psychiatry, 2022-01, Vol.12 (1), p.16-16, Article 16

2022

Volltextzugriff (PDF)

Problematic substance use in depressed adolescents: Prevalence and clinical correlates

Addictive behaviors reports, 2024-06, Vol.19, p.100539, Article 100539

2024

Volltextzugriff (PDF)

Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?

JAMA psychiatry (Chicago, Ill.), 2023-12, Vol.80 (12), p.1187

2023

Volltextzugriff (PDF)

Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?

Molecular psychiatry, 2022-02, Vol.27 (2), p.1095-1102

2022

Volltextzugriff (PDF)

‘Stateless’ Rohingyas: persecution, displacement and complex community development

Community development journal, 2022-04, Vol.57 (2), p.192-212

Jha, Manish K

2022

Volltextzugriff (PDF)

A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adults

Neurobiology of stress, 2023-01, Vol.22, p.100505-100505, Article 100505

2023

Volltextzugriff (PDF)

When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips

The American journal of psychiatry, 2018-12, Vol.175 (12), p.1176-1184

2018

Volltextzugriff (PDF)

1 – 25 von 347

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(294)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(345)

Erscheinungsjahr

n.n

Thema

Science & Technology
(194)
Life Sciences & Biomedicine
(158)
Humans
(100)
Psychiatry
(87)
Adult
(49)
Neurosciences & Neurology
(46)
Depression
(44)
Female
(44)
Male
(44)
Depressive Disorder, Major - Drug Therapy
(37)
Mental Depression
(35)
Antidepressants
(32)
Treatment Outcome
(32)
Social Sciences
(30)
Middle Aged
(29)
Neurosciences
(29)
Antidepressive Agents - Therapeutic Use
(28)
Adolescent
(25)
Clinical Neurology
(25)
Major Depressive Disorder
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Beyond Consumption: India's New Middle Class in the Neo-Liberal Times

Pharmacological Treatments for Patients with Treatment-Resistant Depression

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder

Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation

Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial

Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients

A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project

Smoking status links habenular volume to glycated hemoglobin: Findings from the Human Connectome Project-Young Adult

The clinical, economic, and patient‐centric burden of insomnia symptom severity in adults with major depressive disorder in the United States

Is C-reactive protein ready for prime time in the selection of antidepressant medications?

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape

Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial

Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review

A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory

Problematic substance use in depressed adolescents: Prevalence and clinical correlates

Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?

Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?

‘Stateless’ Rohingyas: persecution, displacement and complex community development

A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adults

When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips

Suchergebnisse filtern